How do I evaluate whether a pharmacovigilance and safety platform is credible and unbiased?

To judge whether a pharmacovigilance and safety platform is credible and unbiased, look at it from four angles: governance, data quality, methods, and transparency. A platform can have impressive dashboards and still be misleading if any of those are weak.

1) Check who runs it and who pays for it

• Ownership and funding: Who owns the platform? Is it funded by a manufacturer, insurer, law firm, regulator, or independent consortium?
• Conflicts of interest: Are conflicts clearly disclosed for the company, the leadership, and any advisory board?
• Editorial independence: If it publishes analyses or rankings, can it operate without sponsor control over conclusions?

Red flags: undisclosed sponsorship, vague “industry partners,” or no governance structure.

2) Examine the data sources

A credible platform should clearly state:

• Where the data come from: spontaneous reports, EHRs, claims, registries, literature, clinical trials, social media, poison centers, etc.
• Coverage and completeness: what populations, geographies, and time periods are included?
• Known limitations: underreporting, duplicates, missing denominator data, reporting bias, coding changes.

Red flags: claiming causality from spontaneous reports alone, or not saying what data are excluded.

3) Evaluate the methods

Ask whether the platform uses defensible pharmacovigilance methods:

• Signal detection approach: disproportionality, Bayesian methods, time-to-onset analyses, observed-versus-expected, case series, etc.
• Confounding control: does it adjust for age, sex, comorbidities, polypharmacy, indication, channeling bias?
• Case validation: are signals clinically reviewed, medically adjudicated, or simply algorithmic?
• Reproducibility: can methods be audited or replicated?

Red flags: black-box scores with no explanation, no sensitivity analyses, or presenting “signals” as proof of harm.

4) Look for transparency and reproducibility

A trustworthy platform should:

• Publish methods documentation
• Provide definitions and coding lists where possible
• Disclose update frequency
• Explain how it handles duplicates, de-duplication, missingness, and data lag
• Distinguish signal, association, and causation

Red flags: “proprietary AI” with no methodological detail; no way to trace why a signal was flagged.

5) Compare against external references

Validate the platform by checking whether:

• Known safety issues are detected appropriately
• Known false positives are not overstated
• Its findings align with regulatory safety communications, peer-reviewed literature, and other independent databases

A good platform doesn’t need to match everything else, but major unexplained discrepancies deserve scrutiny.

6) Assess whether it presents balanced interpretation

A credible platform should:

• State both benefits and risks
• Quantify uncertainty
• Avoid sensational language
• Avoid implying that every reported event is drug-caused

Red flags: cherry-picked examples, fear-based wording, or one-sided conclusions.

7) Check regulatory and scientific credibility

• Is it used or referenced by recognized regulators, academic centers, or professional societies?
• Are there peer-reviewed publications describing its methods and validation?
• Has it been independently audited or benchmarked?

8) Ask practical questions

You can use these directly:

1. What are your data sources and what are their limitations?
2. How do you detect signals?
3. How do you handle confounding, duplicate reports, and missing data?
4. What is your conflict-of-interest policy?
5. Can independent users reproduce your results?
6. How do you distinguish signal generation from causality assessment?
7. Have your methods been validated against known safety issues?
8. What proportion of signals are later confirmed, refuted, or remain uncertain?

Simple scorecard

A platform is more credible if it:

• Is transparent about ownership and funding
• Uses well-described, validated methods
• Clearly states limitations and uncertainty
• Separates signal detection from causal claims
• Allows independent scrutiny
• Has independent validation

If you want, I can also give you:

• a 1-page vendor evaluation checklist,
• a red-flag checklist, or
• a scorecard template you can use to compare platforms side by side.